Only show
results from:

Sort results by:

Display preferences
274 results sorted by relevancy Results per page:
Inflazyme Completes GlycoDesign Acquisition.
Canadian Corporate News; Jun 5, 2003; 700+ Words ...additive to and expand on Inflazyme's LSAID programs. - Inflazyme's product pipeline is further expanded by the addition...acquisition of GlycoDesign, Inflazyme now adds an additional...program with ATH and a further research program with...
Inflazyme Enters into Agreement to Acquire GlycoDesign; Expanding its Franchise in Inflammation and Strengthening its Product Pipeline.
Business Wire; Apr 9, 2003; 700+ Words ...The acquisition will expand Inflazyme's franchise in inflammation...President & CEO of Inflazyme Pharmaceuticals said today...acquisition of GlycoDesign will add further anti-inflammatory technology...part of our strategy to grow Inflazyme into a leading biopharmaceutical...
Inflazyme and Z-Tech Postpone Special Meetings Until April 11, 2008
CCNMatthews Newswire; Mar 31, 2008; 700+ Words ...from such registration. About Inflazyme Inflazyme Pharmaceuticals is a biopharmaceutical...respiratory and inflammatory diseases. Further information on the Company may...obtained from its website at www.inflazyme.com or on SEDAR at www.sedar...
Inflazyme and Z-Tech Receive Interim Court Order for the Calling and Conduct of the Special Meetings of Securityholders to Consider the Merger Between Inflazyme and Z-Tech
CCNMatthews Newswire; Feb 20, 2008; 700+ Words ...from such registration. About Inflazyme Inflazyme Pharmaceuticals is a biopharmaceutical...respiratory and inflammatory diseases. Further information on the Company may...obtained from its website at www.inflazyme.com or on SEDAR at www.sedar...
Inflazyme Receives Notification of Approval of IND by FDA for Potential New Asthma Therapy.
Canadian Corporate News; Jan 29, 2003; 700+ Words ...diseases being developed by Inflazyme scientists from a new series of LSAIDs, the IPL12 series. Inflazyme and Aventis recently announced...development of both programs. Inflazyme may receive up to US$90...diseases of the eye and skin. Further novel LSAIDs, from different...
Inflazyme and Hoechst Marion Roussel to Collaborate on Novel Allergy, Asthma and Respiratory Disease Therapies.
PR Newswire; Feb 11, 1999; 700+ Words ...treatment for allergies. Inflazyme will be responsible for the...have the option to take over further development and commercialization...and the IPL576 compound. Inflazyme will retain rights to any...The agreement will provide Inflazyme with an up-front licensing...
Inflazyme closes $4.9 million investment from Hoechst Marion Roussel.
PR Newswire; Jul 13, 1999; 700+ Words ...of the collaboration, Inflazyme is responsible for the...payment of a milestone to Inflazyme. Hoechst Marion Roussel...then be responsible for further development and commercialization of the product. Inflazyme is currently exploring...
Inflazyme to Acquire Adprotech Limited; Gains New Inflammation Research Technology and Clinical Program.
Business Wire; Apr 7, 2004; 700+ Words ...technology will be additive to Inflazyme's on-going research with...today said, "In merging with Inflazyme, we recognize the opportunity...acquisition of Adprotech will further strengthen Inflazyme's position as a leader in...
Inflazyme signs collaborative agreement with Hoechst Marion Roussel for development of asthma and allergy therapeutics.
PR Newswire; May 14, 1999; 700+ Words ...McBeath, President and CEO of Inflazyme said the partnership brings...of significant benefits to Inflazyme. ``This agreement provides...research that could lead to further novel products for the treatment...committed to working with Inflazyme to explore potential breakthroughs...
Inflazyme and Z-Tech Postpone Their Respective Special Meetings to April 3, 2008
CCNMatthews Newswire; Feb 15, 2008; 700+ Words ...SEDAR after that date. About Inflazyme Inflazyme Pharmaceuticals is a biopharmaceutical...respiratory and inflammatory diseases. Further information on the Company may...obtained from its website at www.inflazyme.com or on SEDAR at www.sedar...
Inflazyme Pharmaceuticals Announces Closing of Transaction With Biolipox.
Canadian Corporate News; Nov 19, 2007; 700+ Words ...Inflazyme. If accepted to the NEX, Inflazyme would be afforded the opportunity...to a shareholder vote. About Inflazyme Further information on the Company may...obtained from its website at www.inflazyme.com. This news release contains...
Inflazyme Pharmaceuticals Advises on the Proposed Merger of Biolipox, the Proposed Purchaser of Inflazyme's Assets, and Orexo.
Canadian Corporate News; Oct 17, 2007; 700+ Words ...milestones and royalties. Inflazyme has called a special meeting...established sales channels. Orexo further advised that, the current...CEO of the merged entity. Inflazyme has contacted Biolipox and...impact on our transaction with Inflazyme. He further added, We remain...
Inflazyme Pharmaceuticals Does Not Exercise Option With Helicon Therapeutics to PDE4 Inhibitor, IPL455,903, in Learning and Memory Disorders.
Canadian Corporate News; Aug 24, 2007; 700+ Words ...Associated Memory Impairment. Inflazyme reported on the results...that the data may support further clinical studies with IPL455...well as the development of Inflazyme's other PDE4 inhibitors. However, Inflazyme has insufficient cash to...
Inflazyme Pharmaceuticals Names John Hodgman as Chairman of Board of Directors.
Canadian Corporate News; Nov 23, 2005; 700+ Words ...members of the Board. About Inflazyme Inflazyme Pharmaceuticals is a biopharmaceutical...inflammatory diseases worldwide. Further information on the Company may...obtained from its website at www.inflazyme.com. Statements in this news...
Inflazyme Pharmaceuticals Announces Departure of Senior Management.
Canadian Corporate News; Dec 28, 2007; 700+ Words ...Marketwire via COMTEX) -- Inflazyme Pharmaceuticals Ltd. (NEX...opportunities. Their departure will further reduce the burn of the Company...of the early employees at Inflazyme in 1994, and he successfully...his major contributions to Inflazyme during his leadership positions...
Inflazyme Licenses Anti-Thrombotic Catheter Coating.
Canadian Corporate News; Jul 24, 2003; 700+ Words ...obtains a license to use Inflazyme's proprietary anti...of use. In exchange, Inflazyme receives an immediate license fee and may receive further milestone and option payments...Upon commercialization, Inflazyme will receive a further...
Inflazyme and Z-Tech Postpone Special Meetings
CCNMatthews Newswire; Apr 10, 2008; 700+ Words ...from such registration. About Inflazyme Inflazyme Pharmaceuticals is a biopharmaceutical...respiratory and inflammatory diseases. Further information on the Company may...obtained from its website at www.inflazyme.com or on SEDAR at www.sedar...
Canadian Companies Inflazyme, GlycoDesign Plan C$12.8M Merger.
BIOWORLD Today; Nov 4, 2009; 700+ Words ...which case it would pay Inflazyme $10 million. If the product reaches the market, Inflazyme would receive a $30 million...payment and then reap further benefits through a double...McBeath said. Aventis - and Inflazyme - remain "very excited...
CANADIAN COMPANIES INFLAZYME, GLYCODESIGN PLAN C$12.8M MERGER.(pharmaceutical industry )
BIOWORLD Today; Apr 10, 2003; ; 700+ Words ...which case it would pay Inflazyme $10 million. If the product reaches the market, Inflazyme would receive a $30 million...payment and then reap further benefits through a double...McBeath said. Aventis - and Inflazyme - remain "very excited...
Inflazyme and Aventis Expand Collaboration For Respiratory Drug Development Programs.
Canadian Corporate News; Nov 21, 2002; 700+ Words ...Inflammatory Drug) discovered by Inflazyme scientists, which is being developed jointly by Inflazyme and Aventis as a potential...Aventis will now fund all further development of IPL512...Research Committee and Inflazyme will continue to be responsible...
274 results: 1 | 2 | 3 | 4 | 5 | Next >>

Find articles, research, and archives